BamSEC and AlphaSense Join Forces
Learn More

Cytokinetics Incorporated

NASDAQ: CYTK    
Share price (12/23/24): $48.95    
Market cap (12/23/24): $5.777 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 4 pages Sixth Amendment to Lease
12/34/56
EX-10.1
from 10-Q 4 pages August 13, 2024 • Base Salary: You Will Receive a Starting Annual Salary of $560,000 Which Will Be Paid Semi-Monthly in Accordance With the Company’s Normal Payroll Procedures. as an Exempt Employee, You Are Not Eligible for Overtime Pay
12/34/56
EX-10.7
from 10-Q 18 pages Cytokinetics, Incorporated Common Stock Option Purchase Agreement
12/34/56
EX-10.6
from 10-Q 47 pages Ck-586 Revenue Participation Right Purchase Agreement by and Between Cytokinetics, Incorporated and Royalty Pharma Investments 2019 Icav Dated as of May 22, 2024
12/34/56
EX-10.4
from 10-Q 9 pages Amendment No. 1 to Revenue Participation Right Purchase Agreement
12/34/56
EX-10.3
from 10-Q 22 pages Third Amendment and Consent
12/34/56
EX-10.1
from 10-Q 4 pages March 28, 2024 • Base Salary: You Will Receive a Starting Annual Salary of $550,000 Which Will Be Paid Semi-Monthly in Accordance With the Company’s Normal Payroll Procedures. as an Exempt Employee, You Are Not Eligible for Overtime Pay
12/34/56
EX-10.1
from 8-K 10 pages Cytokinetics, Incorporated 2015 Employee Stock Purchase Plan
12/34/56
EX-10.2
from 10-Q 5 pages First_name-Middle_name-Last_name Address_line_1 Address_line_2 City, State-Country-Zipcode Award Number: Plan: Id: Option_number Equity_plan Employee_identifier Unless Otherwise Defined Herein, the Terms Defined in the Cytokinetics, Incorporated Amended and Restated 2004 Equity Incentive Plan (The “Plan”) Shall Have the Same Defined Meanings in This Performance Stock Unit Award Agreement (The “Agreement”). You Have Been Granted an Award of Performance Stock Units (“Psus”), Subject to the Terms and Conditions of the Plan and This Agreement, as Follows: Grant Number: Plan: Id: Date of Grant: Type of Award: Total Number of Psus Granted
12/34/56
EX-10.1
from 10-Q 3 pages Description of Director Compensation
12/34/56
EX-10.6
from 10-K 8 pages Fifth Amendment to Lease
12/34/56
EX-10.1
from 8-K 13 pages Cytokinetics, Incorporated Executive Severance Plan and Summary Plan Description
12/34/56
EX-10
from 10-K 59 pages Cytokinetics, Incorporated Shares of Common Stock (Par Value $0.001 Per Share) Amended and Restated Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-10
from 10-K 11 pages Second Amendment
12/34/56
EX-10
from 10-K 5 pages Consent and Amendment
12/34/56
EX-10
from 10-K 5 pages First and Last Name Address Line 1 Address Line 2 City, State and Zip Code Grant Number: Plan: Id: Date of Grant: Type of Award: Rsus Total Number of Shares Granted: Vesting Schedule: 100% of Rsus Vest on the 1-Year Anniversary of the Date of Grant
12/34/56
EX-10
from 10-K 5 pages First and Last Name Address Line 1 Address Line 2 City, State and Zip Code Grant Number: Plan: Id: Date of Grant: Type of Award: Rsus Total Number of Shares Granted: Vesting Schedule: • 50% of Rsus Vest on the 1-Year Anniversary of the Date of Grant; and • the Remaining 50% of Rsus Vest on the 2-Year Anniversary of the Date of Grant
12/34/56
EX-10
from 10-K 5 pages First and Last Name Address Line 1 Address Line 2 City, State and Zip Code
12/34/56
EX-10
from 10-K 7 pages First and Last Name Address Line 1 Address Line 2 City, State, Zip Code
12/34/56
EX-10
from 10-K 7 pages First and Last Name Address Line 1 Address Line 2 City, State and Zip Code
12/34/56